American Well (AMWL) to Release Quarterly Earnings on Wednesday

American Well (NYSE:AMWL) will release its earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. American Well has set its FY 2025 guidance at EPS and its FY 2024 guidance at EPS.Investors that wish to listen to the company’s conference call can do so using this link.

American Well (NYSE:AMWL) last issued its quarterly earnings results on Wednesday, February 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.19) by $0.02. American Well had a negative return on equity of 40.19% and a negative net margin of 260.63%. The company had revenue of $70.68 million for the quarter, compared to analysts’ expectations of $70.16 million. During the same period last year, the firm earned ($0.22) EPS. The firm’s revenue for the quarter was down 10.8% on a year-over-year basis. On average, analysts expect American Well to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

American Well Stock Performance

Shares of AMWL stock opened at $0.54 on Wednesday. American Well has a 1 year low of $0.50 and a 1 year high of $2.74. The stock has a market cap of $156.66 million, a PE ratio of -0.23 and a beta of 1.00. The business’s fifty day moving average is $0.88 and its 200-day moving average is $1.09.

Insider Buying and Selling

In related news, CFO Robert Shepardson sold 319,214 shares of American Well stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total value of $347,943.26. Following the transaction, the chief financial officer now directly owns 2,845,148 shares in the company, valued at approximately $3,101,211.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Robert Shepardson sold 319,214 shares of American Well stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total transaction of $347,943.26. Following the transaction, the chief financial officer now owns 2,845,148 shares in the company, valued at $3,101,211.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Vukasin Paunovich sold 251,323 shares of American Well stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $1.09, for a total value of $273,942.07. Following the transaction, the executive vice president now owns 2,535,635 shares in the company, valued at approximately $2,763,842.15. The disclosure for this sale can be found here. Insiders have sold 1,169,038 shares of company stock worth $1,267,410 in the last three months. 12.94% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Separately, Morgan Stanley decreased their target price on American Well from $1.75 to $1.00 and set an “equal weight” rating on the stock in a report on Monday, April 15th.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.